Log in to save to my catalogue

Low-Density Lipoprotein Apheresis for the Treatment of Refractory Hyperlipidemia

Low-Density Lipoprotein Apheresis for the Treatment of Refractory Hyperlipidemia

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_72207609

Low-Density Lipoprotein Apheresis for the Treatment of Refractory Hyperlipidemia

About this item

Full title

Low-Density Lipoprotein Apheresis for the Treatment of Refractory Hyperlipidemia

Publisher

Rochester, MN: Elsevier Inc

Journal title

Mayo Clinic proceedings, 2001-10, Vol.76 (10), p.1039-1046

Language

English

Formats

Publication information

Publisher

Rochester, MN: Elsevier Inc

More information

Scope and Contents

Contents

The advent of treatment with 3-hydroxy-3-methylglutaryl coenzyme A inhibitors has meant that, with a combination of diet and drug therapy, adequate control of serum cholesterol concentrations can be achieved in most patients with hypercholesterolemia. However, some patients, primarily those with familial hypercholesterolemia (FH), may require addit...

Alternative Titles

Full title

Low-Density Lipoprotein Apheresis for the Treatment of Refractory Hyperlipidemia

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_72207609

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_72207609

Other Identifiers

ISSN

0025-6196

E-ISSN

1942-5546

DOI

10.4065/76.10.1039

How to access this item